LiverMultiScan Analysis of MRI Scans in HCC
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Hepatobiliary Tumors Tissue Samples Acquisition
- Status
- UNKNOWN
- Phase
- N/A
A Study of Anti-PD-1/CTLA-4 Bispecific AK104 Plus Lenvatinib in First-line Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Lenvatinib in Combination With Camrelizumab as First-Line Therapy in Patients With Advanced HCC
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
To Study the Effects of Addition of Mebendazole to Lenvatinib in Cirrhotics With Advanced Hepatocellular Carcinoma.
- Status
- UNKNOWN
- Phase
- NA
The European NAFLD Registry
- Status
- RECRUITING
- Phase
- N/A
SBRT Versus Ablation for Perivascular Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- NA
Safety and Efficacy of Lenvatinib in Subjects With HCC Progression After First Line Treatment With Checkpoint Inhibitors
- Status
- TERMINATED
- Phase
- N/A
Neo-TACE-HAIC for BCLC B Stage HCC
- Status
- RECRUITING
- Phase
- NA
A Study of Laparoscopic Middle Hepatic Vein Guidance and Traditional Anatomic Hemihepatectomy
- Status
- RECRUITING
- Phase
- NA
Study of Automatic Image Fusion of a CT Volume With Ultrasound During Percutaneous Ablation Treatment of Hepatic Tumors
- Status
- COMPLETED
- Phase
- NA
Study on the Safety and Efficacy of Donafinib Combined With Anti-PD-1 Antibody as Adjuvant Therapy for HCC Patients
- Status
- COMPLETED
- Phase
- PHASE1
Adjuvant Lenvatinib Prevents Recurrence of High-risk Patients With HBV-related HCC After Liver Transplantation
- Status
- COMPLETED
- Phase
- N/A
Combining Biomarkers (AFP, AFP-L3, and PIVKA-II) and Image Tools for Early Detection of Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- NA
Liver Transplant for Larger Hepatocellular Carcinoma in Malatya: The Role of GGT and AFP
- Status
- COMPLETED
- Phase
- N/A
A Study of Sintilimab Combined With Apatinib and Capecitabine in Advanced Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Irreversible Electroporation of Unresectable Liver Tumors
- Status
- WITHDRAWN
- Phase
- NA
Preliminary Antitumor Activity, Safety and Tolerability of Tislelizumab in Combination With Lenvatinib for Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
STOP HCC: Mailed HCV Treatment Outreach Program for HCC Prevention for Elevated LFTs
- Status
- WITHDRAWN
- Phase
- NA
Combination PET With 18F-fluorodeoxyglucose (18F-FDG) and 18 F-choline in Patient With HCC
- Status
- COMPLETED
- Phase
- NA